PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Clinical trial NCT02936323 · COMPLETED
Trial details
- NCT number
- NCT02936323
- Sponsor
- Tarveda Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-08
- Primary completion
- 2020-07-31
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.